17-03-2008 Comments (0)
AciphexAloxiAstellas PharmaAvastinbevacizumabcapecitabineCaracEfudexEisaifluorouracilGenentechHerceptinMGI PharmaNystatinOralPalonosetron hydrochloridePrografProtopicRabeprazole SodiumRamelteonRocheRozeremtacrolimustrastuzumabXeloda
Tokyo continued to tumble in the week to March 10. The Nikkei 225 dropped 3.5% to close at...
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.